{"text": ["Top", "Analyst", "Reports", "for", "Netflix,", "Eli", "Lilly", "&", "BNY", "Mellon"], "created_at": "2018-07-18 22:09:37"}
{"text": ["Top", "Analyst", "Reports", "for", "Netflix,", "Eli", "Lilly", "&", "BNY", "Mellon"], "created_at": "2018-07-18 22:09:37"}
{"text": ["Estimates", "and", "Recommendations", "for", "Eli", "Lilly", "on", "July", "18"], "created_at": "2018-07-18 20:40:02"}
{"text": ["Pfizer,", "Eli", "Lilly", "non-opioid", "pain", "drug", "nears", "finish", "line"], "created_at": "2018-07-18 19:26:00"}
{"text": ["Eli", "Lilly\u2019s", "Q2", "2018", "Estimates:", "Expect", "Revenue", "Growth"], "created_at": "2018-07-18 19:10:02"}
{"text": ["Top", "Analyst", "Reports", "for", "Netflix,", "Eli", "Lilly", "&", "BNY", "Mellon"], "created_at": "2018-07-18 19:02:07"}
{"text": ["What", "to", "Expect", "from", "Eli", "Lilly", "and", "Company\u2019s", "Q2", "2018", "Earnings"], "created_at": "2018-07-18 17:38:27"}
{"text": ["Pfizer-Lilly", "pain", "drug", "meets", "late-stage", "trial", "goals"], "created_at": "2018-07-18 12:51:39"}
{"text": ["Pfizer", "And", "Lilly", "Announce", "Positive", "Top-Line", "Results", "From", "Phase", "3", "Trial", "Of", "Tanezumab", "For", "The", "Treatment", "Of", "Osteoarthritis", "(OA)", "Pain"], "created_at": "2018-07-18 10:45:00"}
{"text": ["Pfizer", "And", "Lilly", "Announce", "Positive", "Results", "From", "Phase", "3", "Trial", "Of", "Tanezumab"], "created_at": "2018-07-18 06:55:00"}
{"text": ["Pfizer", "And", "Lilly", "Announce", "Positive", "Results", "From", "Phase", "3", "Trial", "Of", "Tanezumab"], "created_at": "2018-07-18 06:55:00"}
